Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer

This study is ongoing, but not recruiting participants.

Study NCT00053807 Information provided by National Cancer Institute (NCI)

First Received: February 5, 2003 Last Updated: February 6, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Kidney Cancer

Additional conditions recognized in this trial

Carcinoma, Renal Cell
Kidney Neoplasms

More general conditions related to this trial

Adenocarcinoma
Carcinoma
Kidney Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms

Interventions listed in this trial

aldesleukin
recombinant interferon alfa
fluorouracil
adjuvant therapy

Additional drug interventions recognized in this trial

Adjuvants, Immunologic
Interferon Alfa-2a
Interferon Type I, Recombinant
Interferon-alpha
Interferons
Interleukin-2

Sponsors listed in this trial

European Organization for Research and Treatment of Cancer
University of Glasgow

Back to top of Main Content